Metabolomics Analysis for Defining Serum Biochemical Markers in Colorectal Cancer Patients with Qi Deficiency Syndrome or Yin Deficiency Syndrome

Table 2

Differential metabolites in the plasmas of CRC patients with QD compared with those with ND.

	VIP	mz	rt	Name	t-test	log2(QD/ND)
Up-regulated	1.176	451	14.43	Diphosphate	0.000	4.861
	1.432	248	9.97	Glycine	0.000	2.431
	1.675	80	20.93	Arachidonic acid	0.000	2.236
	1.732	79	9.27	Urea	0.000	2.193
	1.361	157	12.70	Pyroglutamic acid	0.000	2.101
	1.031	137	19.63	Oleic acid	0.000	2.031
	1.37	258	7.43	3-Oxaoct-4-en-11-imine	0.000	2.002
	1.341	248	12.07	Aminomalonic acid	0.000	1.939
	1.099	432	18.81	Inositol	0.000	1.907
	1.18	299	9.77	L-Isoleucine	0.000	1.898
	1.324	188	10.66	Serine	0.000	1.783
	1.557	370	22.69	Monopalmitoylglycerol	0.000	1.711
	1.638	181	9.64	Phosphoric acid	0.000	1.659
	1.102	77	6.22	Carbamate	0.000	1.585
	1.131	170	6.52	Hydroxycyclohexane	0.000	1.559
	1.172	84	16.32	N-α-Acetyl-L-Lysine	0.000	1.446
	1.414	133	7.73	Oxalic acid	0.000	1.415
	1.567	155	11.92	GABA	0.000	1.359
	1.526	57	27.67	Cholesterol	0.000	1.154
	1.543	155	11.58	Ethylamine	0.000	0.777
	1.168	217	17.22	Allose	0.000	0.737
Down-regulated	1.265	73	17.06	d-Glucose	0.000	−0.414
	1.621	75	17.06	Threose	0.000	−1.296
	1.38	321	16.98	d-Galactose	0.000	−1.813
	1.652	221	17.04	Mannose	0.000	−1.815
	1.191	205	16.89	Glucopyranose	0.000	−2.039
	1.34	206	17.70	β-D-Allopyranose	0.000	−2.316